Please check your internet connection and try again.
# Tamsulosin
## Overview
Tamsulosin is an alpha-1 adrenergic antagonist. It selectively blocks alpha-1A and alpha-1D receptors in the prostate, bladder neck, and urethra.
## Primary Indications
* Benign Prostatic Hyperplasia (BPH) - to improve urine flow and reduce symptoms of BPH.
* Kidney Stones - to facilitate the passage of ureteral stones (off-label use).
## Adult Dosing
* **BPH:** 0.4 mg orally once daily. If suboptimal response after 2-4 weeks, increase to 0.8 mg orally once daily.
* **Kidney Stones:** 0.4 mg orally once daily is commonly used. Dosing may vary based on stone size and location according to local protocol.
## Pediatric Dosing
Tamsulosin is not indicated for use in the pediatric population.
## Dose Adjustments
* **Renal Impairment:** No dose adjustment is generally needed for mild to moderate renal impairment. Caution is advised in severe renal impairment (CrCl < 10 mL/min), though no specific dose reduction is recommended.
* **Hepatic Impairment:** Use with caution in patients with mild to moderate hepatic impairment. Tamsulosin is not recommended in severe hepatic impairment.
## Contraindications
* Known hypersensitivity to tamsulosin or any component of the formulation.
* Use in pediatric patients.
## Adverse Effects
Common: Dizziness, headache, abnormal ejaculation (including ejaculatory dysfunction, retrograde ejaculation, anejaculation), insomnia, rhinitis, blurred vision, orthostatic hypotension.
Serious: Hypotension, syncope, priapism, intraoperative floppy iris syndrome (IFIS) during cataract surgery.
## Key Drug Interactions
* **CYP3A4 Inhibitors (e.g., ketoconazole, ritonavir):** May increase tamsulosin exposure. Monitor blood pressure and consider dose reduction if necessary.
* **CYP2D6 Inhibitors (e.g., fluoxetine, paroxetine):** May increase tamsulosin exposure. Monitor blood pressure and consider dose reduction if necessary.
* **Other Antihypertensives (e.g., ACE inhibitors, ARBs, beta-blockers, calcium channel blockers):** Additive hypotensive effects may occur. Monitor blood pressure closely.
* **Phosphodiesterase-5 (PDE5) Inhibitors (e.g., sildenafil, tadalafil):** Increased risk of symptomatic hypotension. Use with caution, monitor blood pressure, and counsel patients on potential dizziness.
## Monitoring
* Blood pressure, particularly after initiating therapy or increasing the dose, and for patients on concomitant antihypertensives.
* Ejaculatory function.
* Signs/symptoms of syncope or dizziness.
* Ophthalmologists should be aware of tamsulosin use prior to cataract surgery due to the risk of IFIS.
## Clinical Pearls
* Tamsulosin exhibits dose-dependent absorption; administration with food may increase bioavailability. However, it is typically taken consistently at the same time, often after breakfast, to minimize variability.
* The 0.8 mg capsule is an extended-release formulation. Do not crush, chew, or open the capsules.
* Dizziness and potential for syncope can occur, especially with the first dose or when standing up quickly. Advise patients to sit or lie down if they experience these symptoms.
* Tamsulosin is commonly used off-label to help pass kidney stones, particularly those less than 10 mm, by relaxing the ureter.
---
***Disclaimer:** This information is intended for healthcare professionals. Always consult the latest prescribing information and relevant guidelines for complete and up-to-date drug details. Dosing and management may vary based on individual patient factors and local protocols.*
